EX-25.1 19 b82802exv25w1.htm EX-25.1 exv25w1
Exhibit 25.1
 
 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM T-1
STATEMENT OF ELIGIBILITY UNDER
THE TRUST INDENTURE ACT OF 1939 OF A
CORPORATION DESIGNATED TO ACT AS TRUSTEE
Check if an Application to Determine Eligibility of
a Trustee Pursuant to Section 305(b)(2)
 
U.S. BANK NATIONAL ASSOCIATION
(Exact name of Trustee as specified in its charter)
31-0841368
I.R.S. Employer Identification No.
     
800 Nicollet Mall    
Minneapolis, Minnesota   55402
(Address of principal executive offices)   (Zip Code)
Thomas E. Tabor
U.S. Bank National Association
100 Wall Street, 16th Floor
New York, NY 10005
(212) 361-6184
(Name, address and telephone number of agent for service)
ALERE INC.
(Issuer with respect to the Securities)
     
Delaware   04-3565120
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
TABLE OF ADDITIONAL REGISTRANTS
         
    State or Other    
    Jurisdiction of   I.R.S. Employer
Exact Name of Additional Registrant as   Incorporation or   Identification
Specified in its Charter   Organization   Number
Alere Health Improvement Company
  Delaware   23-2776413
Alere Health, LLC
  Delaware   26-2564744
Alere Health Systems, Inc.
  Delaware   22-3493126
Alere Healthcare of Illinois, Inc.
  Georgia   58-2068880
Alere Home Monitoring, Inc.
  Delaware   20-0391730
Alere International Holding Corp.
  Delaware   20-0963463
Alere Medical, Inc.
  California   94-3238845
Alere NewCo, Inc.
  Delaware   27-2104833
Alere NewCo II, Inc.
  Delaware   27-2104868

 

 

         
    State or Other    
    Jurisdiction of   I.R.S. Employer
Exact Name of Additional Registrant as   Incorporation or   Identification
Specified in its Charter   Organization   Number
Alere North America, Inc.
  Delaware   26-1444559
Alere San Diego, Inc.
  Delaware   33-0288606
Alere Scarborough, Inc.
  Delaware   20-2507302
Alere Toxicology Services, Inc.
  Louisiana   72-0846066
Alere US Holdings, LLC
  Delaware   26-0349667
Alere Wellology, Inc.
  Delaware   54-1776557
Alere Women’s and Children’s Health, LLC
  Delaware   58-2205984
Ameditech Inc.
  California   33-0859551
Applied Biotech, Inc.
  California   33-0447325
Binax, Inc.
  Delaware   36-4668096
Biosite Incorporated
  Delaware   27-2104785
Cholestech Corporation
  Delaware   94-3065493
First Check Diagnostics Corp.
  Delaware   20-8329751
First Check Ecom, Inc.
  Massachusetts   33-1026518
Free & Clear, Inc.
  Delaware   20-0231080
GeneCare Medical Genetics Center, Inc.
  North Carolina   56-1348485
Hemosense, Inc.
  Delaware   77-0452938
Innovacon, Inc.
  Delaware   20-1100264
Instant Technologies, Inc.
  Virginia   54-1837621
Inverness Medical — Biostar Inc.
  Delaware   91-1929582
Inverness Medical, LLC
  Delaware   26-0392649
IVC Industries, Inc.
  Delaware   22-1567481
Laboratory Specialists of America, Inc.
  Oklahoma   73-1451065
Matria of New York, Inc.
  New York   58-1873062
Matritech, Inc.
  Delaware   26-1436477
Ostex International, Inc.
  Washington   91-1450247
Quality Assured Services, Inc.
  Florida   59-3437644
Redwood Toxicology Laboratory, Inc.
  California   68-0332937
RMD Networks, Inc.
  Delaware   84-1581993
RTL Holdings, Inc.
  Delaware   20-4371685
Scientific Testing Laboratories, Inc.
  Virginia   54-1624514
Selfcare Technology, Inc.
  Delaware   04-3383533
Wampole Laboratories, LLC
  Delaware   37-1485678
ZyCare, Inc.
  North Carolina   56-1398496
     
51 Sawyer Road, Suite 200    
Waltham, Massachusetts   02453
(Address of Principal Executive Offices)   (Zip Code)
8.625% Senior Subordinated Notes Due 2018
(Title of the Indenture Securities)
 
 

2

 

FORM T-1
Item 1.   GENERAL INFORMATION. Furnish the following information as to the Trustee.
  a)   Name and address of each examining or supervising authority to which it is subject.
          Comptroller of the Currency
          Washington, D.C.
  b)   Whether it is authorized to exercise corporate trust powers.
          Yes
Item 2.   AFFILIATIONS WITH OBLIGOR. If the obligor is an affiliate of the Trustee, describe
  each such affiliation.
          None
Items 3-15   Items 3-15 are not applicable because to the best of the Trustee’s knowledge, the obligor is not in default under any Indenture for which the Trustee acts as Trustee.
Item 16.   LIST OF EXHIBITS: List below all exhibits filed as a part of this statement of eligibility and qualification.
  1.   A copy of the Articles of Association of the Trustee.*
 
  2.   A copy of the certificate of authority of the Trustee to commence business.**
 
  3.   A copy of the certificate of authority of the Trustee to exercise corporate trust powers.**
 
  4.   A copy of the existing bylaws of the Trustee.**
 
  5.   A copy of each Indenture referred to in Item 4. Not applicable.
 
  6.   The consent of the Trustee required by Section 321(b) of the Trust Indenture Act of 1939, attached as Exhibit 6.
 
  7.   Report of Condition of the Trustee as of September 30, 2010 published pursuant to law or the requirements of its supervising or examining authority, attached as Exhibit
 
*   Incorporated by reference to Exhibit 25.1 to Amendment No. 2 to registration statement on S-4, Registration Number 333-128217 filed on November 15, 2005.
 
**   Incorporated by reference to Exhibit 25.1 to registration statement on S-4, Registration Number 333-166527 filed on May 5, 2010.

3

 

SIGNATURE
     Pursuant to the requirements of the Trust Indenture Act of 1939, as amended, the Trustee, U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility and qualification to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of New York, State of New York on the 22nd of November, 2010.
         
     
  By:   /s/ Thomas E. Tabor    
    Thomas E. Tabor   
    Vice President   

4

 

         
Exhibit 6
CONSENT
     In accordance with Section 321(b) of the Trust Indenture Act of 1939, the undersigned, U.S. BANK NATIONAL ASSOCIATION hereby consents that reports of examination of the undersigned by Federal, State, Territorial or District authorities may be furnished by such authorities to the Securities and Exchange Commission upon its request therefor.
Dated: November 22, 2010
         
     
  By:   /s/ Thomas E. Tabor    
    Thomas E. Tabor   
    Vice President   
 

5

 

Exhibit 7
U.S. Bank Trust National Association
Statement of Financial Condition
As of September 30, 2010
($000’s)
         
ASSETS
        
1. Cash and balances due from depository institutions (from Schedule RC-A):
        
a. Noninterest-bearing balances and currency and coin (1)
     12,012  
b. Interest-bearing balances (2)
     513,410  
2. Securities:
        
a. Held-to-maturity securities (from Schedule RC-B, column A)
     0  
b. Available-for-sale securities (from Schedule RC-B, column D)
     0  
3. Federal funds sold and securities purchased under agreements to resell:
        
a. Federal funds sold
     0  
b. Securities purchased under agreements to resell (3)
     0  
4. Loans and lease financing receivables (from Schedule RC-C):
        
a. Loans and leases held for sale
     0  
b. Loans and leases, net of unearned income
     0  
c. LESS: Allowance for loan and lease losses
     0  
d. Loans and leases, net of unearned income and allowance (item 4.b minus 4.c)
     0  
5. Trading assets (from Schedule RC-D)
     0  
6. Premises and fixed assets (including capitalized leases)
     532  
7. Other real estate owned (from Schedule RC-M)
     0  
8. Investments in unconsolidated subsidiaries and associated companies
     0  
9. Direct and indirect investments in real estate ventures
     0  
10. Intangible assets:
        
a. Goodwill
     55,362  
b. Other intangible assets (from Schedule RC-M)
     5,019  
11. Other assets (from Schedule RC-F)
     23,153  
12. Total assets (sum of items 1 through 11)
     609,488  
 
(1)   Includes cash items in process of collection and unposted debits.
 
(2)   Includes time certificates of deposit not held for trading.
 
(3)   Includes all securities resale agreements, regardless of maturity.
         
LIABILITIES
        
13. Deposits:
        
a. In domestic offices (sum of totals of columns A and C from Schedule RC-E, part I)
     0  
(1) Noninterest-bearing (1)
     0  
(2) Interest-bearing
     0  
b. Not applicable
        
14. Federal funds purchased and securities sold under agreements to repurchase:
        
a. Federal funds purchased (2)
     0  
b. Securities sold under agreements to repurchase (3)
     0  
15. Trading liabilities (from Schedule RC-D)
     0  
16. Other borrowed money (includes mortgage indebtedness and obligations under capitalized leases) (from Schedule RC-M)
     0  
17. and 18. Not applicable
        
19. Subordinated notes and debentures (4)
     0  
20. Other liabilities (from Schedule RC-G)
     16,448  
21. Total liabilities (sum of items 13 through 20)
     16,448  
22. Not applicable
        
 
        
EQUITY CAPITAL
        
Bank Equity Capital
        
23. Perpetual preferred stock and related surplus
     0  
24. Common stock
     1,000  
25. Surplus (excludes all surplus related to preferred stock)
     505,932  
26. a. Retained earnings
     86,108  
b. Accumulated other comprehensive income (5)
     0  
c. Other equity capital components (6)
     0  

6

 

         
27. a. Total bank equity capital (sum of items 23 through 26.c)
     593,040  
b. Noncontrolling (minority) interests in consolidated subsidiaries
     0  
28. Total equity capital (sum of items 27.a and 27.b)
     593,040  
29. Total liabilities and equity capital (sum of items 21 and 28)
     609,488  

7